CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

By: via Benzinga
CNBC's Biotechnology and Pharmaceuticals reporter Meg Tirrel spoke on Fast Money about potential takeover targets for Gilead Sciences, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.